19 Sep 2023 --- Researchers found that Adonat Premium S-adenosylmethionine (SAMe) – developed by Gnosis by Lesaffre – may repress the PSEN1 gene, a biomarker of Alzheimer’s disease. The study suggests that supplementation with SAMe during the perinatal period may protect offspring against Alzheimer’s disease-related symptoms later in life due to genetic coding delivered from mother to baby. “We hope to educate the public on the elemental importance of SAMe in the human body and its relationships to healthy aging and longevity,” Beatrice Minin, mood and cognitive health market manager at Gnosis by Lesaffre, tells Nutrition Insight.
